Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.

The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.

A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.

The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.

The global Tetanus Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Tetanus Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Tetanus Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Tetanus Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tetanus Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Tetanus Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Tetanus Vaccine sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Tetanus Vaccine Market Report

Report Metric	Details
Report Name	Tetanus Vaccine Market
CAGR	5%
Segment by Type	Diphtheria and tetanus (DT) vaccines Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines Tetanus and diphtheria (Td) vaccines Tetanus, diphtheria, and pertussis (Tdap) vaccines
Segment by Application	Adult Pediatric
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck & Co.,Inc, Sanofi Pasteur SA, Biological E, Dano Vaccine &Biological Pvt.Ltd.,, Panera, Shantha Biotechnics Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Tetanus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Tetanus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tetanus Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tetanus Vaccine Market report?

Ans: The main players in the Tetanus Vaccine Market are Merck & Co.,Inc, Sanofi Pasteur SA, Biological E, Dano Vaccine &Biological Pvt.Ltd.,, Panera, Shantha Biotechnics Ltd

What are the Application segmentation covered in the Tetanus Vaccine Market report?

Ans: The Applications covered in the Tetanus Vaccine Market report are Adult, Pediatric

What are the Type segmentation covered in the Tetanus Vaccine Market report?

Ans: The Types covered in the Tetanus Vaccine Market report are Diphtheria and tetanus (DT) vaccines, Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines, Tetanus and diphtheria (Td) vaccines, Tetanus, diphtheria, and pertussis (Tdap) vaccines

1 Study Coverage

1.1 Tetanus Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Tetanus Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Diphtheria and tetanus (DT) vaccines

1.2.3 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines

1.2.4 Tetanus and diphtheria (Td) vaccines

1.2.5 Tetanus, diphtheria, and pertussis (Tdap) vaccines

1.3 Market by Application

1.3.1 Global Tetanus Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Adult

1.3.3 Pediatric

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Tetanus Vaccine Sales Estimates and Forecasts 2019-2030

2.2 Global Tetanus Vaccine Revenue by Region

2.2.1 Global Tetanus Vaccine Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Tetanus Vaccine Revenue by Region (2019-2024)

2.2.3 Global Tetanus Vaccine Revenue by Region (2025-2030)

2.2.4 Global Tetanus Vaccine Revenue Market Share by Region (2019-2030)

2.3 Global Tetanus Vaccine Sales Estimates and Forecasts 2019-2030

2.4 Global Tetanus Vaccine Sales by Region

2.4.1 Global Tetanus Vaccine Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Tetanus Vaccine Sales by Region (2019-2024)

2.4.3 Global Tetanus Vaccine Sales by Region (2025-2030)

2.4.4 Global Tetanus Vaccine Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Tetanus Vaccine Sales by Manufacturers

3.1.1 Global Tetanus Vaccine Sales by Manufacturers (2019-2024)

3.1.2 Global Tetanus Vaccine Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tetanus Vaccine in 2023

3.2 Global Tetanus Vaccine Revenue by Manufacturers

3.2.1 Global Tetanus Vaccine Revenue by Manufacturers (2019-2024)

3.2.2 Global Tetanus Vaccine Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Tetanus Vaccine Revenue in 2023

3.3 Global Key Players of Tetanus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Tetanus Vaccine Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Tetanus Vaccine, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Tetanus Vaccine, Product Offered and Application

3.8 Global Key Manufacturers of Tetanus Vaccine, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Tetanus Vaccine Sales by Type

4.1.1 Global Tetanus Vaccine Historical Sales by Type (2019-2024)

4.1.2 Global Tetanus Vaccine Forecasted Sales by Type (2025-2030)

4.1.3 Global Tetanus Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Tetanus Vaccine Revenue by Type

4.2.1 Global Tetanus Vaccine Historical Revenue by Type (2019-2024)

4.2.2 Global Tetanus Vaccine Forecasted Revenue by Type (2025-2030)

4.2.3 Global Tetanus Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Tetanus Vaccine Price by Type

4.3.1 Global Tetanus Vaccine Price by Type (2019-2024)

4.3.2 Global Tetanus Vaccine Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Tetanus Vaccine Sales by Application

5.1.1 Global Tetanus Vaccine Historical Sales by Application (2019-2024)

5.1.2 Global Tetanus Vaccine Forecasted Sales by Application (2025-2030)

5.1.3 Global Tetanus Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Tetanus Vaccine Revenue by Application

5.2.1 Global Tetanus Vaccine Historical Revenue by Application (2019-2024)

5.2.2 Global Tetanus Vaccine Forecasted Revenue by Application (2025-2030)

5.2.3 Global Tetanus Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Tetanus Vaccine Price by Application

5.3.1 Global Tetanus Vaccine Price by Application (2019-2024)

5.3.2 Global Tetanus Vaccine Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Tetanus Vaccine Market Size by Type

6.1.1 US & Canada Tetanus Vaccine Sales by Type (2019-2030)

6.1.2 US & Canada Tetanus Vaccine Revenue by Type (2019-2030)

6.2 US & Canada Tetanus Vaccine Market Size by Application

6.2.1 US & Canada Tetanus Vaccine Sales by Application (2019-2030)

6.2.2 US & Canada Tetanus Vaccine Revenue by Application (2019-2030)

6.3 US & Canada Tetanus Vaccine Market Size by Country

6.3.1 US & Canada Tetanus Vaccine Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Tetanus Vaccine Sales by Country (2019-2030)

6.3.3 US & Canada Tetanus Vaccine Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Tetanus Vaccine Market Size by Type

7.1.1 Europe Tetanus Vaccine Sales by Type (2019-2030)

7.1.2 Europe Tetanus Vaccine Revenue by Type (2019-2030)

7.2 Europe Tetanus Vaccine Market Size by Application

7.2.1 Europe Tetanus Vaccine Sales by Application (2019-2030)

7.2.2 Europe Tetanus Vaccine Revenue by Application (2019-2030)

7.3 Europe Tetanus Vaccine Market Size by Country

7.3.1 Europe Tetanus Vaccine Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Tetanus Vaccine Sales by Country (2019-2030)

7.3.3 Europe Tetanus Vaccine Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Tetanus Vaccine Market Size

8.1.1 China Tetanus Vaccine Sales (2019-2030)

8.1.2 China Tetanus Vaccine Revenue (2019-2030)

8.2 China Tetanus Vaccine Market Size by Application

8.2.1 China Tetanus Vaccine Sales by Application (2019-2030)

8.2.2 China Tetanus Vaccine Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Tetanus Vaccine Market Size by Type

9.1.1 Asia Tetanus Vaccine Sales by Type (2019-2030)

9.1.2 Asia Tetanus Vaccine Revenue by Type (2019-2030)

9.2 Asia Tetanus Vaccine Market Size by Application

9.2.1 Asia Tetanus Vaccine Sales by Application (2019-2030)

9.2.2 Asia Tetanus Vaccine Revenue by Application (2019-2030)

9.3 Asia Tetanus Vaccine Sales by Region

9.3.1 Asia Tetanus Vaccine Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Tetanus Vaccine Revenue by Region (2019-2030)

9.3.3 Asia Tetanus Vaccine Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Tetanus Vaccine Market Size by Type

10.1.1 Middle East, Africa and Latin America Tetanus Vaccine Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Tetanus Vaccine Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Tetanus Vaccine Market Size by Application

10.2.1 Middle East, Africa and Latin America Tetanus Vaccine Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Tetanus Vaccine Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Tetanus Vaccine Sales by Country

10.3.1 Middle East, Africa and Latin America Tetanus Vaccine Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Tetanus Vaccine Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Tetanus Vaccine Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 GlaxoSmithKline plc

11.1.1 GlaxoSmithKline plc Company Information

11.1.2 GlaxoSmithKline plc Overview

11.1.3 GlaxoSmithKline plc Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 GlaxoSmithKline plc Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 GlaxoSmithKline plc Recent Developments

11.2 Pfizer,Inc

11.2.1 Pfizer,Inc Company Information

11.2.2 Pfizer,Inc Overview

11.2.3 Pfizer,Inc Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Pfizer,Inc Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Pfizer,Inc Recent Developments

11.3 Merck & Co.,Inc

11.3.1 Merck & Co.,Inc Company Information

11.3.2 Merck & Co.,Inc Overview

11.3.3 Merck & Co.,Inc Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Merck & Co.,Inc Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Merck & Co.,Inc Recent Developments

11.4 Sanofi Pasteur SA

11.4.1 Sanofi Pasteur SA Company Information

11.4.2 Sanofi Pasteur SA Overview

11.4.3 Sanofi Pasteur SA Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Sanofi Pasteur SA Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Sanofi Pasteur SA Recent Developments

11.5 Biological E

11.5.1 Biological E Company Information

11.5.2 Biological E Overview

11.5.3 Biological E Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Biological E Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Biological E Recent Developments

11.6 Dano Vaccine &Biological Pvt.Ltd.,

11.6.1 Dano Vaccine &Biological Pvt.Ltd., Company Information

11.6.2 Dano Vaccine &Biological Pvt.Ltd., Overview

11.6.3 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Dano Vaccine &Biological Pvt.Ltd., Recent Developments

11.7 Panera

11.7.1 Panera Company Information

11.7.2 Panera Overview

11.7.3 Panera Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Panera Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Panera Recent Developments

11.8 Shantha Biotechnics Ltd

11.8.1 Shantha Biotechnics Ltd Company Information

11.8.2 Shantha Biotechnics Ltd Overview

11.8.3 Shantha Biotechnics Ltd Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Shantha Biotechnics Ltd Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Shantha Biotechnics Ltd Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Tetanus Vaccine Industry Chain Analysis

12.2 Tetanus Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Tetanus Vaccine Production Mode & Process

12.4 Tetanus Vaccine Sales and Marketing

12.4.1 Tetanus Vaccine Sales Channels

12.4.2 Tetanus Vaccine Distributors

12.5 Tetanus Vaccine Customers

13 Market Dynamics

13.1 Tetanus Vaccine Industry Trends

13.2 Tetanus Vaccine Market Drivers

13.3 Tetanus Vaccine Market Challenges

13.4 Tetanus Vaccine Market Restraints

14 Key Findings in The Global Tetanus Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Dano Vaccine &Biological Pvt.Ltd.,

Panera

Shantha Biotechnics Ltd

List of Tables

Table 1. Global Tetanus Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Diphtheria and tetanus (DT) vaccines

Table 3. Major Manufacturers of Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines

Table 4. Major Manufacturers of Tetanus and diphtheria (Td) vaccines

Table 5. Major Manufacturers of Tetanus, diphtheria, and pertussis (Tdap) vaccines

Table 6. Global Tetanus Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Tetanus Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Tetanus Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Tetanus Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Tetanus Vaccine Revenue Market Share by Region (2019-2024)

Table 11. Global Tetanus Vaccine Revenue Market Share by Region (2025-2030)

Table 12. Global Tetanus Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Tetanus Vaccine Sales by Region (2019-2024) & (K Units)

Table 14. Global Tetanus Vaccine Sales by Region (2025-2030) & (K Units)

Table 15. Global Tetanus Vaccine Sales Market Share by Region (2019-2024)

Table 16. Global Tetanus Vaccine Sales Market Share by Region (2025-2030)

Table 17. Global Tetanus Vaccine Sales by Manufacturers (2019-2024) & (K Units)

Table 18. Global Tetanus Vaccine Sales Share by Manufacturers (2019-2024)

Table 19. Global Tetanus Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Tetanus Vaccine Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Tetanus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Tetanus Vaccine Price by Manufacturers 2019-2024 (USD/Unit)

Table 23. Global Tetanus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Tetanus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tetanus Vaccine as of 2023)

Table 25. Global Key Manufacturers of Tetanus Vaccine, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Tetanus Vaccine, Product Offered and Application

Table 27. Global Key Manufacturers of Tetanus Vaccine, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Tetanus Vaccine Sales by Type (2019-2024) & (K Units)

Table 30. Global Tetanus Vaccine Sales by Type (2025-2030) & (K Units)

Table 31. Global Tetanus Vaccine Sales Share by Type (2019-2024)

Table 32. Global Tetanus Vaccine Sales Share by Type (2025-2030)

Table 33. Global Tetanus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Tetanus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Tetanus Vaccine Revenue Share by Type (2019-2024)

Table 36. Global Tetanus Vaccine Revenue Share by Type (2025-2030)

Table 37. Tetanus Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 38. Global Tetanus Vaccine Price Forecast by Type (2025-2030) & (USD/Unit)

Table 39. Global Tetanus Vaccine Sales by Application (2019-2024) & (K Units)

Table 40. Global Tetanus Vaccine Sales by Application (2025-2030) & (K Units)

Table 41. Global Tetanus Vaccine Sales Share by Application (2019-2024)

Table 42. Global Tetanus Vaccine Sales Share by Application (2025-2030)

Table 43. Global Tetanus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Tetanus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Tetanus Vaccine Revenue Share by Application (2019-2024)

Table 46. Global Tetanus Vaccine Revenue Share by Application (2025-2030)

Table 47. Tetanus Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 48. Global Tetanus Vaccine Price Forecast by Application (2025-2030) & (USD/Unit)

Table 49. US & Canada Tetanus Vaccine Sales by Type (2019-2024) & (K Units)

Table 50. US & Canada Tetanus Vaccine Sales by Type (2025-2030) & (K Units)

Table 51. US & Canada Tetanus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Tetanus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Tetanus Vaccine Sales by Application (2019-2024) & (K Units)

Table 54. US & Canada Tetanus Vaccine Sales by Application (2025-2030) & (K Units)

Table 55. US & Canada Tetanus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Tetanus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Tetanus Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Tetanus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Tetanus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Tetanus Vaccine Sales by Country (2019-2024) & (K Units)

Table 61. US & Canada Tetanus Vaccine Sales by Country (2025-2030) & (K Units)

Table 62. Europe Tetanus Vaccine Sales by Type (2019-2024) & (K Units)

Table 63. Europe Tetanus Vaccine Sales by Type (2025-2030) & (K Units)

Table 64. Europe Tetanus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Tetanus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Tetanus Vaccine Sales by Application (2019-2024) & (K Units)

Table 67. Europe Tetanus Vaccine Sales by Application (2025-2030) & (K Units)

Table 68. Europe Tetanus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Tetanus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Tetanus Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Tetanus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Tetanus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Tetanus Vaccine Sales by Country (2019-2024) & (K Units)

Table 74. Europe Tetanus Vaccine Sales by Country (2025-2030) & (K Units)

Table 75. China Tetanus Vaccine Sales by Type (2019-2024) & (K Units)

Table 76. China Tetanus Vaccine Sales by Type (2025-2030) & (K Units)

Table 77. China Tetanus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Tetanus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Tetanus Vaccine Sales by Application (2019-2024) & (K Units)

Table 80. China Tetanus Vaccine Sales by Application (2025-2030) & (K Units)

Table 81. China Tetanus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Tetanus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Tetanus Vaccine Sales by Type (2019-2024) & (K Units)

Table 84. Asia Tetanus Vaccine Sales by Type (2025-2030) & (K Units)

Table 85. Asia Tetanus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Tetanus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Tetanus Vaccine Sales by Application (2019-2024) & (K Units)

Table 88. Asia Tetanus Vaccine Sales by Application (2025-2030) & (K Units)

Table 89. Asia Tetanus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Tetanus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Tetanus Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Tetanus Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Tetanus Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Tetanus Vaccine Sales by Region (2019-2024) & (K Units)

Table 95. Asia Tetanus Vaccine Sales by Region (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Tetanus Vaccine Sales by Type (2019-2024) & (K Units)

Table 97. Middle East, Africa and Latin America Tetanus Vaccine Sales by Type (2025-2030) & (K Units)

Table 98. Middle East, Africa and Latin America Tetanus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Tetanus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Tetanus Vaccine Sales by Application (2019-2024) & (K Units)

Table 101. Middle East, Africa and Latin America Tetanus Vaccine Sales by Application (2025-2030) & (K Units)

Table 102. Middle East, Africa and Latin America Tetanus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Tetanus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Tetanus Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Tetanus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Tetanus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Tetanus Vaccine Sales by Country (2019-2024) & (K Units)

Table 108. Middle East, Africa and Latin America Tetanus Vaccine Sales by Country (2025-2030) & (K Units)

Table 109. GlaxoSmithKline plc Company Information

Table 110. GlaxoSmithKline plc Description and Major Businesses

Table 111. GlaxoSmithKline plc Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 112. GlaxoSmithKline plc Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. GlaxoSmithKline plc Recent Developments

Table 114. Pfizer,Inc Company Information

Table 115. Pfizer,Inc Description and Major Businesses

Table 116. Pfizer,Inc Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 117. Pfizer,Inc Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Pfizer,Inc Recent Developments

Table 119. Merck & Co.,Inc Company Information

Table 120. Merck & Co.,Inc Description and Major Businesses

Table 121. Merck & Co.,Inc Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 122. Merck & Co.,Inc Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Merck & Co.,Inc Recent Developments

Table 124. Sanofi Pasteur SA Company Information

Table 125. Sanofi Pasteur SA Description and Major Businesses

Table 126. Sanofi Pasteur SA Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 127. Sanofi Pasteur SA Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Sanofi Pasteur SA Recent Developments

Table 129. Biological E Company Information

Table 130. Biological E Description and Major Businesses

Table 131. Biological E Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 132. Biological E Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Biological E Recent Developments

Table 134. Dano Vaccine &Biological Pvt.Ltd., Company Information

Table 135. Dano Vaccine &Biological Pvt.Ltd., Description and Major Businesses

Table 136. Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 137. Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Dano Vaccine &Biological Pvt.Ltd., Recent Developments

Table 139. Panera Company Information

Table 140. Panera Description and Major Businesses

Table 141. Panera Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 142. Panera Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Panera Recent Developments

Table 144. Shantha Biotechnics Ltd Company Information

Table 145. Shantha Biotechnics Ltd Description and Major Businesses

Table 146. Shantha Biotechnics Ltd Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 147. Shantha Biotechnics Ltd Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. Shantha Biotechnics Ltd Recent Developments

Table 149. Key Raw Materials Lists

Table 150. Raw Materials Key Suppliers Lists

Table 151. Tetanus Vaccine Distributors List

Table 152. Tetanus Vaccine Customers List

Table 153. Tetanus Vaccine Market Trends

Table 154. Tetanus Vaccine Market Drivers

Table 155. Tetanus Vaccine Market Challenges

Table 156. Tetanus Vaccine Market Restraints

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Tetanus Vaccine Product Picture

Figure 2. Global Tetanus Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Tetanus Vaccine Market Share by Type in 2023 & 2030

Figure 4. Diphtheria and tetanus (DT) vaccines Product Picture

Figure 5. Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines Product Picture

Figure 6. Tetanus and diphtheria (Td) vaccines Product Picture

Figure 7. Tetanus, diphtheria, and pertussis (Tdap) vaccines Product Picture

Figure 8. Global Tetanus Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Tetanus Vaccine Market Share by Application in 2023 & 2030

Figure 10. Adult

Figure 11. Pediatric

Figure 12. Tetanus Vaccine Report Years Considered

Figure 13. Global Tetanus Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Tetanus Vaccine Revenue 2019-2030 (US$ Million)

Figure 15. Global Tetanus Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Tetanus Vaccine Revenue Market Share by Region (2019-2030)

Figure 17. Global Tetanus Vaccine Sales 2019-2030 ((K Units)

Figure 18. Global Tetanus Vaccine Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Tetanus Vaccine Sales YoY (2019-2030) & (K Units)

Figure 20. US & Canada Tetanus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Tetanus Vaccine Sales YoY (2019-2030) & (K Units)

Figure 22. Europe Tetanus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Tetanus Vaccine Sales YoY (2019-2030) & (K Units)

Figure 24. China Tetanus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Tetanus Vaccine Sales YoY (2019-2030) & (K Units)

Figure 26. Asia (excluding China) Tetanus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Tetanus Vaccine Sales YoY (2019-2030) & (K Units)

Figure 28. Middle East, Africa and Latin America Tetanus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Tetanus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Tetanus Vaccine in the World: Market Share by Tetanus Vaccine Revenue in 2023

Figure 31. Global Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Tetanus Vaccine Sales Market Share by Type (2019-2030)

Figure 33. Global Tetanus Vaccine Revenue Market Share by Type (2019-2030)

Figure 34. Global Tetanus Vaccine Sales Market Share by Application (2019-2030)

Figure 35. Global Tetanus Vaccine Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Tetanus Vaccine Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Tetanus Vaccine Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Tetanus Vaccine Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Tetanus Vaccine Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Tetanus Vaccine Revenue Share by Country (2019-2030)

Figure 41. US & Canada Tetanus Vaccine Sales Share by Country (2019-2030)

Figure 42. U.S. Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Tetanus Vaccine Sales Market Share by Type (2019-2030)

Figure 45. Europe Tetanus Vaccine Revenue Market Share by Type (2019-2030)

Figure 46. Europe Tetanus Vaccine Sales Market Share by Application (2019-2030)

Figure 47. Europe Tetanus Vaccine Revenue Market Share by Application (2019-2030)

Figure 48. Europe Tetanus Vaccine Revenue Share by Country (2019-2030)

Figure 49. Europe Tetanus Vaccine Sales Share by Country (2019-2030)

Figure 50. Germany Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 51. France Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 55. China Tetanus Vaccine Sales Market Share by Type (2019-2030)

Figure 56. China Tetanus Vaccine Revenue Market Share by Type (2019-2030)

Figure 57. China Tetanus Vaccine Sales Market Share by Application (2019-2030)

Figure 58. China Tetanus Vaccine Revenue Market Share by Application (2019-2030)

Figure 59. Asia Tetanus Vaccine Sales Market Share by Type (2019-2030)

Figure 60. Asia Tetanus Vaccine Revenue Market Share by Type (2019-2030)

Figure 61. Asia Tetanus Vaccine Sales Market Share by Application (2019-2030)

Figure 62. Asia Tetanus Vaccine Revenue Market Share by Application (2019-2030)

Figure 63. Asia Tetanus Vaccine Revenue Share by Region (2019-2030)

Figure 64. Asia Tetanus Vaccine Sales Share by Region (2019-2030)

Figure 65. Japan Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 69. India Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Tetanus Vaccine Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Tetanus Vaccine Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Tetanus Vaccine Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Tetanus Vaccine Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Tetanus Vaccine Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America Tetanus Vaccine Sales Share by Country (2019-2030)

Figure 76. Brazil Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 79. Israel Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries Tetanus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 81. Tetanus Vaccine Value Chain

Figure 82. Tetanus Vaccine Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions